Lamivir Tablet 100 mg
Lamivir Tablet 100 mg Uses, Dosage, Side Effects, Food Interaction and all others data.
| Trade Name | Lamivir Tablet 100 mg |
| Generic | Lamivudine [For Chronic Hepatitis B] |
| Weight | 100 mg |
| Type | Tablet |
| Therapeutic Class | Hepatic viral infections (Hepatitis B) |
| Manufacturer | Incepta Pharmaceuticals Ltd. |
| Available Country | Bangladesh |
| Last Updated: | October 19, 2023 at 6:27 am |
Uses
Lamivudine is indicated for the treatment of chronic hepatitis B associated with evidence of hepatitis B viral replication and active liver inflammation.Dosage
Lamivir Tablet 100 mg dosage
The recommended oral dose of Lamivudine for the treatment of chronic hepatitis B in adults is 100 mg once daily.Side Effects
Several serious adverse events reported with lamivudine (lactic acidosis and severe hepatomegaly with steatosis, post treatment exacerbations of hepatitis B, pancreatitis, and emergence of viral mutants associated with reduced drug susceptibility and diminished treatment response). Malaise, fatigue, fever, ENT infections, sore throat, nausea, vomiting, abdominal discomfort, pain, diarrhea, myalgia, arthralgia, headache, skin rashes may occur. Lactic acidosis and severe hepatomegaly with steatosis, have been reported.Precaution
Patients should be assessed before beginning treatment and during treatment with lamivudine by a physician experienced in the management of chronic hepatitis B.Interaction
Trimethoprim 160 mg / Sulfamethoxazole 800 mg once daily has been shown to increase lamivudine exposure (AUC). The effect of higher doses of trimethoprim /sulfamethoxazole on lamivudine pharmacokinetics has not been investigated.Pregnancy & Breastfeeding use
There is no adequate and well-controlled study in pregnant women. Lamivudine should be used during pregnancy only if the potential benefits outweigh the risks. Although it is not known if lamivudine is excreted in human milk, there is the potential for adverse effects from lamivudine in nursing infants. Mothers should be instructed not to breast feed if they are receiving lamivudine.Contraindication
Lamivudine is contraindicated in patients hypersensitive to any of the components of the product.Special Warning
It is recommended that doses of Lamivudine should be adjusted in accordance with renal function. Dosage adjustment of Lamivudine in accordance with creatinine clearance is as follows: CrCl 50 ml/min: 100 mg once daily CrCl 30-49 ml/min: 100 mg first dose, then 50 mg once daily CrCl 15-29 ml/min: 100 mg first dose, then 25 mg once daily CrCl 5-14 ml/min: 35 mg first dose, then 15 mg once daily CrCl <5 ml/min: 35 mg first dose, then 10 mg once daily Use in children: Safety and efficacy of lamivudine for the treatment of chronic hepatitis B in children have not been established.Storage Condition
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.Innovators Monograph
You find simplified version here Lamivir Tablet 100 mg
